Research & Development

The Research & Development team at Orano Med is dedicated to advancing the field of nuclear medicine by developing high-purity lead-212 (Pb-212) production processes for targeted alpha therapy (TAT). This team conducts cutting-edge research to create innovative cancer treatments that precisely target and destroy cancer cells while minimizing damage to healthy tissues. Through collaboration, they also focus on peptide drug discovery and the development of radiopharmaceuticals, ensuring comprehensive support from initial research to clinical trials.